Biotech - Press Releases

Date	Title	Company
29-Nov-2022	Creative Enzymes Expands Its Service Offering with the Launch of Custom Enzyme Blends	Creative Enzymes
29-Nov-2022	Creative Enzymes Provides DNA Molecular Weight Markers and Ladders	Creative Enzymes
29-Nov-2022	EverImmune appoints Prof. Laurence Zitvogel as president of scientific advisory board	Andrew Lloyd Associates
29-Nov-2022	Rewind Therapeutics Appoints Dr. Stephen Burbidge to its Management Team	Rewind Therapeutics
29-Nov-2022	CD Genomics Expands Its Sequencing Portfolio with the Launch of Whole Exome Sequencing	CD Genomics
29-Nov-2022	MicrobioSeq Boosts Scientific Research with Gene Expression Analysis	CD Genomics
25-Nov-2022	CD Formulation Stresses the Importance of Increased Bioavailability Excipients in Drug Formulation	CD Formulation
25-Nov-2022	CD Formulation Launches GalNAc Coupling Modification Services for the Development of Drug Delivery Systems	CD Formulation
25-Nov-2022	Alfa Chemistry Shows Expertise in Customized Design and Synthesis of Silazanes	Alfa Chemistry
24-Nov-2022	Allero Therapeutics Receives EIC Horizon Grant to Advance Treatment of Celiac Disease	Allero Therapeutics
24-Nov-2022	OptiBiotix: Scientific community must double-down on efforts to reduce cardiovascular risk following presentation at US Global Engage Conference	OptiBiotix Health Plc
23-Nov-2022	Iktos Partners with Medicines for Malaria Venture in Anti-Malarial Drug Discovery	Iktos
23-Nov-2022	HpVac Appoints Joana Vitte, MD, PhD, as Chief Scientific Officer	HpVac SA
23-Nov-2022	Clinion Achieves GDPR Compliance, continuing its commitment to data privacy and security	Clinion
22-Nov-2022	ImaginAb Executes New License and Supply Agreement for CD8 ImmunoPET Technology with TriSalus Life Sciences	ImaginAb
22-Nov-2022	BOC Sciences Continues to Power Up RNA Therapeutics with siRNA Products and Services	BOC Sciences
21-Nov-2022	Novozymes Is at the Forefront of Digital R&D, Turning Data Into an Advantage With Benchling R&D Cloud	Benchling
21-Nov-2022	CPHI Frankfurt Report predicts huge funding overhang to drive contract services growth	Defacto communications
21-Nov-2022	CPHI Frankfurt Report predicts ‘biologics outsourcing to surge in 2023, as China’s innovation engine stalls’	Defacto communications
21-Nov-2022	SHIONOGI, ACTIVE CITIZENSHIP NETWORK AND MEPS ADVOCATE FOR URGENT POLICY IMPLEMENTATION IN EU MEMBER STATES AT EU PARLIAMENT EVENT TO ADDRESS THE GROWING THREAT OF ANTIMICROBIAL RESISTANCE	Shionogi